38,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
19 °P sammeln
  • Gebundenes Buch

A detailed examination of China's increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.

Produktbeschreibung
A detailed examination of China's increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.
Autorenporträt
Gunter Festel, Huenenberg, Switzerland / Andreas Kreimeyer, BASF AG, Ludwigshafen, Germany / Udo Oels, Bayer AG, Leverkusen, Germany / Maximilian von Zedtwitz, Beijing, China
Rezensionen
From the reviews:

"China, with its potential market of 1.3 billion consumers, has resurrected the western world's stagnant economic outlook. ... This is an interesting book on the global chemical industry and the business practices of multinational companies." (Helmut Hügel, Chemistry in Australia, December, 2005)